Our Materials
CIAO’s educational materials were developed by the San Francisco Department of Public Health and reviewed by a panel of experts. Materials are regularly updated to include new scientific literature and changes in policy and programming.
​
Our materials are meant to be used and shared! If you are interested in using, adapting, or learning more about our materials, please fill out our contact form.
Last Updated: Apr. 2024
The CIAO teams aims to decrease opioid and stimulant related morbidity and mortality by promoting balanced approaches to care. This Guide was created as a resource for healthcare providers who want to provide a higher standard of care for their patients who use drugs.
​
San Francisco based providers can sign up for more in-depth one-on-one educational sessions with a member of the CIAO team here.
Opioids and Chronic Pain: A guide for primary care providers
Last Updated: Feb. 2023
Last Updated: Feb. 2021
Last Updated: May 2019
Last Updated: Jun. 2020
Opioid Safety and How to Use Naloxone: A guide for patients and caregivers (brochure)
​
Naloxone brochure is available in Spanish, Russian, Vietnamese, Chinese, Korean, and Tagalog.
Last Updated: May 2019
Last Updated: Dec. 2020
Last Updated: June 2018
Pending updates to reflect changes in DEA waiver requirement
Last Updated: Dec. 2020
As of December 2022, there is no longer a federal requirement for practitioners to have an X-Waiver to prescribe Buprenorphine for the treatment of Opioid Use Disorder (OUD). Only a standard DEA registration number is required. Information from SAMHSA on the intricacies of these changes can be found here.